Impact of Chronic Kidney Disease on In-Hospital Outcomes of Hospitalizations With Acute Limb Ischemia Undergoing Endovascular Therapy.
Harsh P PatelDean DecterSamarthkumar ThakkarMahesh Anantha-NarayananAshish K UmeshAakash R ShethSalman ZahidBhavin A PatelToralben PatelHiteshkumar DevaniVrushali ShahPreet Mayank DoshiSmit PatelMariam ShariffDevina AdaljaSaraschandra VallabhajosyulaRajkumar P DoshiPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2022)
Current guidelines are not clear for the optimum first line treatment of acute limb ischemia, especially in patients with advanced kidney disease as compared to normal/mild kidney disease patients. We found that advanced kidney disease is a significant risk factor for worse in-hospital morbidity and mortality. Furthermore, patients with acute limb ischemia and advanced kidney disease is associated with significantly higher resource utilization as compared to patients with normal/mild kidney disease. This study suggests shared decision making between treating physician and patients when considering endovascular therapy for the treatment of acute limb ischemia in patients with advanced kidney disease.
Keyphrases
- end stage renal disease
- chronic kidney disease
- liver failure
- newly diagnosed
- ejection fraction
- aortic dissection
- peritoneal dialysis
- healthcare
- respiratory failure
- primary care
- prognostic factors
- emergency department
- drug induced
- stem cells
- type diabetes
- intensive care unit
- mesenchymal stem cells
- adverse drug
- patient reported
- acute care
- skeletal muscle
- clinical practice